Skip to main content

Animations

MJFF Publications

6331 - 6340 of 9134 Results
Title
Year
  • Year
  • 2016
  • 2018
  • 2019
  • 2024
  • 2022
  • 2018
  • 2015
  • 2020
  • 2016
  • 2022
  • Summary Details
    OPEN
    Title: N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2016.10.001
    Citation Count: 45
  • Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
    2018
    Summary Details
    RESTRICTED
    Title: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066
    Citation Count: 894
  • Summary Details
    OPEN
    Title: The neuro-toxin MPTP does not prevent reproduction in marmosets
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.12688/mniopenres.12818.2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Clinical genetic testing in Parkinson’s disease should become part of routine patient care
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awae181
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoids
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.202107135
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12632
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Network structure of brain atrophy in de novo Parkinson's disease
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.08440
    Citation Count: 260
  • Summary Details
    OPEN
    Title: Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2020.102391
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 1079
  • Summary Details
    OPEN
    Title: Multishank Thin‐Film Neural Probes and Implantation System for High‐Resolution Neural Recording Applications
    Journal Name: Advanced Electronic Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/aelm.202200883
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.